Lysophosphatidic Acid Signaling in the Nervous System

Neuron

Volumn 85, Issue 4, 2015, Pages 669-682

  Yung, Yun C ^a   Stoddard, Nicole C ^a,b   Mirendil, Hope ^a   Chun, Jerold ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOTAXIN; G PROTEIN COUPLED RECEPTOR; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE; MONOACYLGLYCEROL; LYSOPHOSPHOLIPID;

ALZHEIMER DISEASE; ANHEDONIA; ANXIETY; ASTROCYTE; BRAIN BLOOD VESSEL; BRAIN CANCER; BRAIN DEVELOPMENT; CELL CYCLE PROGRESSION; CHOROID PLEXUS; ENPP2 GENE; EX VIVO STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; HUMAN; HYDROCEPHALUS; HYPOXIA; IN VIVO STUDY; INHIBITORY POSTSYNAPTIC POTENTIAL; LIPID DEGRADATION; MICROGLIA; NERVOUS SYSTEM; NERVOUS SYSTEM INJURY; NEURAL STEM CELL; NEUROPATHIC PAIN; NONHUMAN; OLIGODENDROGLIA; PHENOTYPE; PHOSPHOLIPID METABOLISM; PREPULSE INHIBITION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCHWANN CELL; SIGNAL TRANSDUCTION; STRESS; ANIMAL; CYTOLOGY; METABOLISM;

ANIMALS; HUMANS; LYSOPHOSPHOLIPIDS; NERVOUS SYSTEM; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84925435090     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2015.01.009     Document Type: Review

References (174)

1. Aaltonen N., Lehtonen M., Varonen K., Goterris G.A., Laitinen J.T. Lipid phosphate phosphatase inhibitors locally amplify lysophosphatidic acid LPA1 receptor signalling in rat brain cryosections without affecting global LPA degradation. BMC Pharmacol. 2012, 12:7.
2. Anliker B., Choi J.W., Lin M.E., Gardell S.E., Rivera R.R., Kennedy G., Chun J. Lysophosphatidic acid (LPA) and its receptor, LPA1, influence embryonic schwann cell migration, myelination, and cell-to-axon segregation. Glia 2013, 61:2009-2022.
3. Annabi B., Lachambre M.P., Plouffe K., Sartelet H., Béliveau R. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling. Mol. Carcinog. 2009, 48:910-919.
4. Aoki J. Mechanisms of lysophosphatidic acid production. Semin. Cell Dev. Biol. 2004, 15:477-489.
5. Aoki J., Taira A., Takanezawa Y., Kishi Y., Hama K., Kishimoto T., Mizuno K., Saku K., Taguchi R., Arai H. Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J.Biol. Chem. 2002, 277:48737-48744.
6. Armati P.J., Mathey E.K. An update on Schwann cell biology-immunomodulation, neural regulation and other surprises. J.Neurol. Sci. 2013, 333:68-72.
7. Bächner D., Ahrens M., Betat N., Schröder D., Gross G. Developmental expression analysis of murine autotaxin (ATX). Mech. Dev. 1999, 84:121-125.
8. Bandoh K., Aoki J., Taira A., Tsujimoto M., Arai H., Inoue K. Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors. FEBS Lett. 2000, 478:159-165.
9. Bernhart E., Kollroser M., Rechberger G., Reicher H., Heinemann A., Schratl P., Hallström S., Wintersperger A., Nusshold C., DeVaney T., et al. Lysophosphatidic acid receptor activation affects the C13NJ microglia cell line proteome leading to alterations in glycolysis, motility, and cytoskeletal architecture. Proteomics 2010, 10:141-158.
10. Bieberich E. It's a lipid's world: bioactive lipid metabolism and signaling in neural stem cell differentiation. Neurochem. Res. 2012, 37:1208-1229.
11. Blaschke A.J., Staley K., Chun J. Widespread programmed cell death in proliferative and postmitotic regions of the fetal cerebral cortex. Development 1996, 122:1165-1174.
12. Blaschke A.J., Weiner J.A., Chun J. Programmed cell death is a universal feature of embryonic and postnatal neuroproliferative regions throughout the central nervous system. J.Comp. Neurol. 1998, 396:39-50.
13. Brindley D.N., Pilquil C. Lipid phosphate phosphatases and signaling. J.Lipid Res. 2009, 50:S225-S230.
14. Campbell D.S., Holt C.E. Apoptotic pathway and MAPKs differentially regulate chemotropic responses of retinal growth cones. Neuron 2003, 37:939-952.
15. 1 receptor knockout mice. PLoS ONE 2011, 6:e25522.
16. Castilla-Ortega E., Escuredo L., Bilbao A., Pedraza C., Orio L., Estivill-Torrús G., Santín L.J., de Fonseca F.R., Pavón F.J. 1-Oleoyl lysophosphatidic acid: a new mediator of emotional behavior in rats. PLoS ONE 2014, 9:e85348.
17. Cervera P., Tirard M., Barron S., Allard J., Trottier S., Lacombe J., Daumas-Duport C., Sokoloff P. Immunohistological localization of the myelinating cell-specific receptor LP(A1). Glia 2002, 38:126-136.
18. Choi J.W., Herr D.R., Noguchi K., Yung Y.C., Lee C.W., Mutoh T., Lin M.E., Teo S.T., Park K.E., Mosley A.N., Chun J. LPA receptors: subtypes and biological actions. Annu. Rev. Pharmacol. Toxicol. 2010, 50:157-186.
19. Chun J., Brinkmann V. A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya). Discov. Med. 2011, 12:213-228.
20. Chun J., Hla T., Lynch K.R., Spiegel S., Moolenaar W.H. International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature. Pharmacol. Rev. 2010, 62:579-587.
21. Contos J.J., Fukushima N., Weiner J.A., Kaushal D., Chun J. Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior. Proc. Natl. Acad. Sci. USA 2000, 97:13384-13389.
22. Contos J.J., Ishii I., Fukushima N., Kingsbury M.A., Ye X., Kawamura S., Brown J.H., Chun J. Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2). Mol. Cell. Biol. 2002, 22:6921-6929.
23. Corcoran A., O'Connor J.J. Hypoxia-inducible factor signalling mechanisms in the central nervous system. Acta Physiol. (Oxf.) 2013, 208:298-310.
24. Crack P.J., Zhang M., Morganti-Kossmann M.C., Morris A.J., Wojciak J.M., Fleming J.K., Karve I., Wright D., Sashindranath M., Goldshmit Y., et al. Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes. J.Neuroinflammation 2014, 11:37.
25. Cunningham M.O., Hunt J., Middleton S., LeBeau F.E., Gillies M.J., Davies C.H., Maycox P.R., Whittington M.A., Racca C. Region-specific reduction in entorhinal gamma oscillations and parvalbumin-immunoreactive neurons in animal models of psychiatric illness. J.Neurosci. 2006, 26:2767-2776.
26. de Anda F.C., Pollarolo G., Da Silva J.S., Camoletto P.G., Feiguin F., Dotti C.G. Centrosome localization determines neuronal polarity. Nature 2005, 436:704-708.
27. Domínguez-Pinos M.D., Páez P., Jiménez A.J., Weil B., Arráez M.A., Pérez-Fígares J.M., Rodríguez E.M. Ependymal denudation and alterations of the subventricular zone occur in human fetuses with a moderate communicating hydrocephalus. J.Neuropathol. Exp. Neurol. 2005, 64:595-604.
28. Dubin A.E., Bahnson T., Weiner J.A., Fukushima N., Chun J. Lysophosphatidic acid stimulates neurotransmitter-like conductance changes that precede GABA and L-glutamate in early, presumptive cortical neuroblasts. J.Neurosci. 1999, 19:1371-1381.
29. Dubin A.E., Herr D.R., Chun J. Diversity of lysophosphatidic acid receptor-mediated intracellular calcium signaling in early cortical neurogenesis. J.Neurosci. 2010, 30:7300-7309.
30. Dutta S., Wang F.Q., Wu H.S., Mukherjee T.J., Fishman D.A. The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC). Gynecol. Oncol. 2011, 123:129-137.
31. Eichholtz T., Jalink K., Fahrenfort I., Moolenaar W.H. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem. J. 1993, 291:677-680.
32. Eichmann A., Thomas J.L. Molecular parallels between neural and vascular development. Cold Spring Harb Perspect Med 2013, 3:a006551.
33. English D., Kovala A.T., Welch Z., Harvey K.A., Siddiqui R.A., Brindley D.N., Garcia J.G. Induction of endothelial cell chemotaxis by sphingosine 1-phosphate and stabilization of endothelial monolayer barrier function by lysophosphatidic acid, potential mediators of hematopoietic angiogenesis. J.Hematother. Stem Cell Res. 1999, 8:627-634.
34. Fotopoulou S., Oikonomou N., Grigorieva E., Nikitopoulou I., Paparountas T., Thanassopoulou A., Zhao Z., Xu Y., Kontoyiannis D.L., Remboutsika E., Aidinis V. ATX expression and LPA signalling are vital for the development of the nervous system. Dev. Biol. 2010, 339:451-464.
35. Frohnert P.W., Stonecypher M.S., Carroll S.L. Lysophosphatidic acid promotes the proliferation of adult Schwann cells isolated from axotomized sciatic nerve. J.Neuropathol. Exp. Neurol. 2003, 62:520-529.
36. Frugier T., Crombie D., Conquest A., Tjhong F., Taylor C., Kulkarni T., McLean C., Pébay A. Modulation of LPA receptor expression in the human brain following neurotrauma. Cell. Mol. Neurobiol. 2011, 31:569-577.
37. Fuentes E., Nadal A., McNaughton P.A. Lysophospholipids trigger calcium signals but not DNA synthesis in cortical astrocytes. Glia 1999, 28:272-276.
38. Fujita R., Ma Y., Ueda H. Lysophosphatidic acid-induced membrane ruffling and brain-derived neurotrophic factor gene expression are mediated by ATP release in primary microglia. J.Neurochem. 2008, 107:152-160.
39. Fukumizu M., Takashima S., Becker L.E. Neonatal posthemorrhagic hydrocephalus: neuropathologic and immunohistochemical studies. Pediatr. Neurol. 1995, 13:230-234.
40. Fukushima N., Morita Y. Actomyosin-dependent microtubule rearrangement in lysophosphatidic acid-induced neurite remodeling of young cortical neurons. Brain Res. 2006, 1094:65-75.
41. Fukushima N., Ishii I., Habara Y., Allen C.B., Chun J. Dual regulation of actin rearrangement through lysophosphatidic acid receptor in neuroblast cell lines: actin depolymerization by Ca(2+)-alpha-actinin and polymerization by rho. Mol. Biol. Cell 2002, 13:2692-2705.
42. Fukushima N., Weiner J.A., Kaushal D., Contos J.J., Rehen S.K., Kingsbury M.A., Kim K.Y., Chun J. Lysophosphatidic acid influences the morphology and motility of young, postmitotic cortical neurons. Mol. Cell. Neurosci. 2002, 20:271-282.
43. Fukushima N., Shano S., Moriyama R., Chun J. Lysophosphatidic acid stimulates neuronal differentiation of cortical neuroblasts through the LPA1-G(i/o) pathway. Neurochem. Int. 2007, 50:302-307.
44. Furukawa A., Kita K., Toyomoto M., Fujii S., Inoue S., Hayashi K., Ikeda K. Production of nerve growth factor enhanced in cultured mouse astrocytes by glycerophospholipids, sphingolipids, and their related compounds. Mol. Cell. Biochem. 2007, 305:27-34.
45. Furuta D., Yamane M., Tsujiuchi T., Moriyama R., Fukushima N. Lysophosphatidic acid induces neurite branch formation through LPA3. Mol. Cell. Neurosci. 2012, 50:21-34.
46. Geach T.J., Faas L., Devader C., Gonzalez-Cordero A., Tabler J.M., Brunsdon H., Isaacs H.V., Dale L. An essential role for LPA signalling in telencephalon development. Development 2014, 141:940-949.
47. Goldshmit Y., Munro K., Leong S.Y., Pébay A., Turnley A.M. LPA receptor expression in the central nervous system in health and following injury. Cell Tissue Res. 2010, 341:23-32.
48. Greenberg D.A., Jin K. From angiogenesis to neuropathology. Nature 2005, 438:954-959.
49. Greig L.C., Woodworth M.B., Galazo M.J., Padmanabhan H., Macklis J.D. Molecular logic of neocortical projection neuron specification, development and diversity. Nat. Rev. Neurosci. 2013, 14:755-769.
50. Groves A., Kihara Y., Chun J. Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy. J.Neurol. Sci. 2013, 328:9-18.
51. Hadley D., Wu Z.L., Kao C., Kini A., Mohamed-Hadley A., Thomas K., Vazquez L., Qiu H., Mentch F., Pellegrino R., et al. The impact of the metabotropic glutamate receptor and other gene family interaction networks on autism. Nat. Commun. 2014, 5:4074. AGP Consortium.
52. Hall S.M. The effect of injections of lysophosphatidyl choline into white matter of the adult mouse spinal cord. J.Cell Sci. 1972, 10:535-546.
53. Hama K., Aoki J., Fukaya M., Kishi Y., Sakai T., Suzuki R., Ohta H., Yamori T., Watanabe M., Chun J., Arai H. Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1. J.Biol. Chem. 2004, 279:17634-17639.
54. Harrison S.M., Reavill C., Brown G., Brown J.T., Cluderay J.E., Crook B., Davies C.H., Dawson L.A., Grau E., Heidbreder C., et al. LPA1 receptor-deficient mice have phenotypic changes observed in psychiatric disease. Mol. Cell. Neurosci. 2003, 24:1170-1179.
55. Hayashi M., Okabe K., Kato K., Okumura M., Fukui R., Fukushima N., Tsujiuchi T. Differential function of lysophosphatidic acid receptors in cell proliferation and migration of neuroblastoma cells. Cancer Lett. 2012, 316:91-96.
56. Hecht J.H., Weiner J.A., Post S.R., Chun J. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J.Cell Biol. 1996, 135:1071-1083.
57. Herr K.J., Herr D.R., Lee C.W., Noguchi K., Chun J. Stereotyped fetal brain disorganization is induced by hypoxia and requires lysophosphatidic acid receptor 1 (LPA1) signaling. Proc. Natl. Acad. Sci. USA 2011, 108:15444-15449.
58. Hoelzinger D.B., Nakada M., Demuth T., Rosensteel T., Reavie L.B., Berens M.E. Autotaxin: a secreted autocrine/paracrine factor that promotes glioma invasion. J.Neurooncol. 2008, 86:297-309.
59. Hosogaya S., Yatomi Y., Nakamura K., Ohkawa R., Okubo S., Yokota H., Ohta M., Yamazaki H., Koike T., Ozaki Y. Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity. Ann. Clin. Biochem. 2008, 45:364-368.
60. Houben A.J., Moolenaar W.H. Autotaxin and LPA receptor signaling in cancer. Cancer Metastasis Rev. 2011, 30:557-565.
61. Hu X., Liou A.K., Leak R.K., Xu M., An C., Suenaga J., Shi Y., Gao Y., Zheng P., Chen J. Neurobiology of microglial action in CNS injuries: receptor-mediated signaling mechanisms and functional roles. Prog. Neurobiol. 2014, 119-120:60-84.
62. Hwang S.H., Shin E.J., Shin T.J., Lee B.H., Choi S.H., Kang J., Kim H.J., Kwon S.H., Jang C.G., Lee J.H., et al. Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates Alzheimer's disease-related neuropathies: involvement of non-amyloidogenic processing. J.Alzheimers Dis. 2012, 31:207-223.
63. Inoue M., Rashid M.H., Fujita R., Contos J.J., Chun J., Ueda H. Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat. Med. 2004, 10:712-718.
64. Inoue M., Ma L., Aoki J., Chun J., Ueda H. Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain. Mol. Pain 2008, 4:6.
65. Inoue M., Xie W., Matsushita Y., Chun J., Aoki J., Ueda H. Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid. Neuroscience 2008, 152:296-298.
66. Jang Y., Lee M.H., Lee J., Jung J., Lee S.H., Yang D.J., Kim B.W., Son H., Lee B., Chang S., et al. TRPM2 mediates the lysophosphatidic acid-induced neurite retraction in the developing brain. Pflugers Arch. 2014, 466:1987-1998.
67. Jesionowska A., Cecerska E., Dolegowska B. Methods for quantifying lysophosphatidic acid in body fluids: a review. Anal. Biochem. 2014, 453:38-43.
68. Johansson P.A. The choroid plexuses and their impact on developmental neurogenesis. Front Neurosci 2014, 8:340.
69. Kato K., Fukui R., Okabe K., Tanabe E., Kitayoshi M., Fukushima N., Tsujiuchi T. Constitutively active lysophosphatidic acid receptor-1 enhances the induction of matrix metalloproteinase-2. Biochem. Biophys. Res. Commun. 2012, 417:790-793.
70. Khalil B.D., El-Sibai M. Rho GTPases in primary brain tumor malignancy and invasion. J.Neurooncol. 2012, 108:333-339.
71. Kihara Y., Maceyka M., Spiegel S., Chun J. Lysophospholipid receptor nomenclature review: IUPHAR Review 8. Br. J. Pharmacol. 2014, 171:3575-3594.
72. Kihara Y., Mizuno H., Chun J. Lysophospholipid receptors in drug discovery. Exp. Cell Res. 2014, Published December 8, 2014. 10.1016/j.yexcr.2014.11.020.
73. Kingsbury M.A., Rehen S.K., Contos J.J., Higgins C.M., Chun J. Non-proliferative effects of lysophosphatidic acid enhance cortical growth and folding. Nat. Neurosci. 2003, 6:1292-1299.
74. Kishi Y., Okudaira S., Tanaka M., Hama K., Shida D., Kitayama J., Yamori T., Aoki J., Fujimaki T., Arai H. Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid. J.Biol. Chem. 2006, 281:17492-17500.
75. Kobashi H., Yaoi T., Oda R., Okajima S., Fujiwara H., Kubo T., Fushiki S. Lysophospholipid receptors are differentially expressed in rat terminal Schwann cells, as revealed by a single cell rt-PCR and insitu hybridization. Acta Histochem. Cytochem. 2006, 39:55-60.
76. Lee J., Park S.Y., Lee E.K., Park C.G., Chung H.C., Rha S.Y., Kim Y.K., Bae G.U., Kim B.K., Han J.W., Lee H.Y. Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression. Clin. Cancer Res. 2006, 12:6351-6358.
77. Lee Z., Cheng C.T., Zhang H., Subler M.A., Wu J., Mukherjee A., Windle J.J., Chen C.K., Fang X. Role of LPA4/p2y9/GPR23 in negative regulation of cell motility. Mol. Biol. Cell 2008, 19:5435-5445.
78. Lee L.Y., Farooqui A.A., Dawe G.S., Burgunder J.M., Ong W.Y. Role of phospholipase A(2) in prepulse inhibition of the auditory startle reflex in rats. Neurosci. Lett. 2009, 453:6-8.
79. Lee S.J., No Y.R., Dang D.T., Dang L.H., Yang V.W., Shim H., Yun C.C. Regulation of hypoxia-inducible factor 1α (HIF-1α) by lysophosphatidic acid is dependent on interplay between p53 and Krüppel-like factor 5. J.Biol. Chem. 2013, 288:25244-25253.
80. Li Y., Gonzalez M.I., Meinkoth J.L., Field J., Kazanietz M.G., Tennekoon G.I. Lysophosphatidic acid promotes survival and differentiation of rat Schwann cells. J.Biol. Chem. 2003, 278:9585-9591.
81. Lin C.I., Chen C.N., Lin P.W., Chang K.J., Hsieh F.J., Lee H. Lysophosphatidic acid regulates inflammation-related genes in human endothelial cells through LPA1 and LPA3. Biochem. Biophys. Res. Commun. 2007, 363:1001-1008.
82. Lin C.-I., Chen C.-N., Huang M.-T., Lee S.-J., Lin C.-H., Chang C.-C., Lee H. Lysophosphatidic acid upregulates vascular endothelial growth factor-C and tube formation in human endothelial cells through LPA(1/3), COX-2, and NF-kappaB activation- and EGFR transactivation-dependent mechanisms. Cell. Signal. 2008, 20:1804-1814.
83. Lin C.-H., Lane H.-Y., Tsai G.E. Glutamate signaling in the pathophysiology and therapy of schizophrenia. Pharmacol. Biochem. Behav. 2012, 100:665-677.
84. Lin M.E., Rivera R.R., Chun J. Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain. J.Biol. Chem. 2012, 287:17608-17617.
85. Lovestone S., Killick R., Di Forti M., Murray R. Schizophrenia as a GSK-3 dysregulation disorder. Trends Neurosci. 2007, 30:142-149.
86. Ma L., Uchida H., Nagai J., Inoue M., Aoki J., Ueda H. Evidence for de novo synthesis of lysophosphatidic acid in the spinal cord through phospholipase A2 and autotaxin in nerve injury-induced neuropathic pain. J.Pharmacol. Exp. Ther. 2010, 333:540-546.
87. Ma L., Nagai J., Chun J., Ueda H. An LPA species (18:1 LPA) plays key roles in the self-amplification of spinal LPA production in the peripheral neuropathic pain model. Mol. Pain 2013, 9:29.
88. Manning T.J., Parker J.C., Sontheimer H. Role of lysophosphatidic acid and rho in glioma cell motility. Cell Motil. Cytoskeleton 2000, 45:185-199.
89. Mao Y., Ge X., Frank C.L., Madison J.M., Koehler A.N., Doud M.K., Tassa C., Berry E.M., Soda T., Singh K.K., et al. Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling. Cell 2009, 136:1017-1031.
90. McMahon H.T., Gallop J.L. Membrane curvature and mechanisms of dynamic cell membrane remodelling. Nature 2005, 438:590-596.
91. Meng H., Yuan Y., Lee V.M. Loss of sphingosine kinase 1/S1P signaling impairs cell growth and survival of neurons and progenitor cells in the developing sensory ganglia. PLoS ONE 2011, 6:e27150.
92. Mirendil H., Lin M.E., Chun J. Lysophosphatidic acid (LPA) receptor signaling. Lysophospholipid Receptors: Signaling and Biochemistry 2013, 1-39. Wiley, Hoboken. J. Chun, T. Hla, W.H. Moolenaar, S. Spiegel (Eds.).
93. Mizugishi K., Yamashita T., Olivera A., Miller G.F., Spiegel S., Proia R.L. Essential role for sphingosine kinases in neural and vascular development. Mol. Cell. Biol. 2005, 25:11113-11121.
94. Möller T., Musante D.B., Ransom B.R. Lysophosphatidic acid-induced calcium signals in cultured rat oligodendrocytes. Neuroreport 1999, 10:2929-2932.
95. Möller T., Contos J.J., Musante D.B., Chun J., Ransom B.R. Expression and function of lysophosphatidic acid receptors in cultured rodent microglial cells. J.Biol. Chem. 2001, 276:25946-25952.
96. Motiejunaite R., Aranda J., Kazlauskas A. Pericytes prevent regression of endothelial cell tubes by accelerating metabolism of lysophosphatidic acid. Microvasc. Res. 2014, 93:62-71.
97. Muessel M.J., Harry G.J., Armstrong D.L., Storey N.M. SDF-1α and LPA modulate microglia potassium channels through rho gtpases to regulate cell morphology. Glia 2013, 61:1620-1628.
98. Musazzi L., Di Daniel E., Maycox P., Racagni G., Popoli M. Abnormalities in α/β-CaMKII and related mechanisms suggest synaptic dysfunction in hippocampus of LPA1 receptor knockout mice. Int. J. Neuropsychopharmacol. 2011, 14:941-953.
99. Nogaroli L., Yuelling L.M., Dennis J., Gorse K., Payne S.G., Fuss B. Lysophosphatidic acid can support the formation of membranous structures and an increase in MBP mRNA levels in differentiating oligodendrocytes. Neurochem. Res. 2009, 34:182-193.
100. Noguchi K., Herr D., Mutoh T., Chun J. Lysophosphatidic acid (LPA) and its receptors. Curr. Opin. Pharmacol. 2009, 9:15-23.
101. Offermanns S., Mancino V., Revel J.P., Simon M.I. Vascular system defects and impaired cell chemokinesis as a result of Galpha13 deficiency. Science 1997, 275:533-536.
102. Ohsawa M., Miyabe Y., Katsu H., Yamamoto S., Ono H. Identification of the sensory nerve fiber responsible for lysophosphatidic acid-induced allodynia in mice. Neuroscience 2013, 247:65-74.
103. Ohuchi H., Hamada A., Matsuda H., Takagi A., Tanaka M., Aoki J., Arai H., Noji S. Expression patterns of the lysophospholipid receptor genes during mouse early development. Dev. Dyn. 2008, 237:3280-3294.
104. Okudaira S., Yukiura H., Aoki J. Biological roles of lysophosphatidic acid signaling through its production by autotaxin. Biochimie 2010, 92:698-706.
105. On N.H., Savant S., Toews M., Miller D.W. Rapid and reversible enhancement of blood-brain barrier permeability using lysophosphatidic acid. J.Cereb. Blood Flow Metab. 2013, 33:1944-1954.
106. Pagès C., Simon M.-F., Valet P., Saulnier-Blache J.S. Lysophosphatidic acid synthesis and release. Prostaglandins Other Lipid Mediat. 2001, 64:1-10.
107. Pasternack S.M., von Kügelgen I., Al Aboud K., Lee Y.-A., Rüschendorf F., Voss K., Hillmer A.M., Molderings G.J., Franz T., Ramirez A., et al. G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth. Nat. Genet. 2008, 40:329-334.
108. Pébay A., Torrens Y., Toutant M., Cordier J., Glowinski J., Tencé M. Pleiotropic effects of lysophosphatidic acid on striatal astrocytes. Glia 1999, 28:25-33.
109. Perrakis A., Moolenaar W.H. Autotaxin: structure-function and signaling. J.Lipid Res. 2014, 55:1010-1018.
110. Ploeger A., Raijmakers M.E., van der Maas H.L., Galis F. The association between autism and errors in early embryogenesis: what is the causal mechanism?. Biol. Psychiatry 2010, 67:602-607.
111. Prinz M., Priller J. Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat. Rev. Neurosci. 2014, 15:300-312.
112. Ptaszynska M.M., Pendrak M.L., Stracke M.L., Roberts D.D. Autotaxin signaling via lysophosphatidic acid receptors contributes to vascular endothelial growth factor-induced endothelial cell migration. Mol. Cancer Res. 2010, 8:309-321.
113. Ramakers G.J., Moolenaar W.H. Regulation of astrocyte morphology by RhoA and lysophosphatidic acid. Exp. Cell Res. 1998, 245:252-262.
114. Rao T.S., Lariosa-Willingham K.D., Lin F.F., Palfreyman E.L., Yu N., Chun J., Webb M. Pharmacological characterization of lysophospholipid receptor signal transduction pathways in rat cerebrocortical astrocytes. Brain Res. 2003, 990:182-194.
115. Ren Y., Guo L., Tang X., Apparsundaram S., Kitson C., Deguzman J., Fuentes M.E., Coyle L., Majmudar R., Allard J., et al. Comparing the differential effects of LPA on the barrier function of human pulmonary endothelial cells. Microvasc. Res. 2013, 85:59-67.
116. Renbäck K., Inoue M., Ueda H. Lysophosphatidic acid-induced, pertussis toxin-sensitive nociception through a substance P release from peripheral nerve endings in mice. Neurosci. Lett. 1999, 270:59-61.
117. Roberts C., Winter P., Shilliam C.S., Hughes Z.A., Langmead C., Maycox P.R., Dawson L.A. Neurochemical changes in LPA1 receptor deficient mice-a putative model of schizophrenia. Neurochem. Res. 2005, 30:371-377.
118. Rosenberg S.S., Spitzer N.C. Calcium signaling in neuronal development. Cold Spring Harb. Perspect. Biol. 2011, 3:a004259.
119. Rossy J., Ma Y., Gaus K. The organisation of the cell membrane: do proteins rule lipids?. Curr. Opin. Chem. Biol. 2014, 20:54-59.
120. Ruhrberg C., Bautch V.L. Neurovascular development and links to disease. Cell. Mol. Life Sci. 2013, 70:1675-1684.
121. Ruisanchez É., Dancs P., Kerék M., Németh T., Faragó B., Balogh A., Patil R., Jennings B.L., Liliom K., Malik K.U., et al. Lysophosphatidic acid induces vasodilation mediated by LPA1 receptors, phospholipase C, and endothelial nitric oxide synthase. FASEB J. 2014, 28:880-890.
122. Salhia B., Rutten F., Nakada M., Beaudry C., Berens M., Kwan A., Rutka J.T. Inhibition of Rho-kinase affects astrocytoma morphology, motility, and invasion through activation of Rac1. Cancer Res. 2005, 65:8792-8800.
123. Santin L.J., Bilbao A., Pedraza C., Matas-Rico E., López-Barroso D., Castilla-Ortega E., Sánchez-López J., Riquelme R., Varela-Nieto I., de la Villa P., et al. Behavioral phenotype of maLPA1-null mice: increased anxiety-like behavior and spatial memory deficits. Genes Brain Behav. 2009, 8:772-784.
124. Sato K., Horiuchi Y., Jin Y., Malchinkhuu E., Komachi M., Kondo T., Okajima F. Unmasking of LPA1 receptor-mediated migration response to lysophosphatidic acid by interleukin-1β-induced attenuation of Rho signaling pathways in rat astrocytes. J.Neurochem. 2011, 117:164-174.
125. Savaskan N.E., Rocha L., Kotter M.R., Baer A., Lubec G., van Meeteren L.A., Kishi Y., Aoki J., Moolenaar W.H., Nitsch R., Bräuer A.U. Autotaxin (NPP-2) in the brain: cell type-specific expression and regulation during development and after neurotrauma. Cell. Mol. Life Sci. 2007, 64:230-243.
126. Savitz S.I., Dhallu M.S., Malhotra S., Mammis A., Ocava L.C., Rosenbaum P.S., Rosenbaum D.M. EDG receptors as a potential therapeutic target in retinal ischemia-reperfusion injury. Brain Res. 2006, 1118:168-175.
127. Sayas C.L., Moreno-Flores M.T., Avila J., Wandosell F. The neurite retraction induced by lysophosphatidic acid increases Alzheimer's disease-like Tau phosphorylation. J.Biol. Chem. 1999, 274:37046-37052.
128. Schilling T., Stock C., Schwab A., Eder C. Functional importance of Ca2+-activated K+ channels for lysophosphatidic acid-induced microglial migration. Eur. J. Neurosci. 2004, 19:1469-1474.
129. Schleicher S.M., Thotala D.K., Linkous A.G., Hu R., Leahy K.M., Yazlovitskaya E.M., Hallahan D.E. Autotaxin and LPA receptors represent potential molecular targets for the radiosensitization of murine glioma through effects on tumor vasculature. PLoS ONE 2011, 6:e22182.
130. Seasholtz T.M., Radeff-Huang J., Sagi S.A., Matteo R., Weems J.M., Cohen A.S., Feramisco J.R., Brown J.H. Rho-mediated cytoskeletal rearrangement in response to LPA is functionally antagonized by Rac1 and PIP2. J.Neurochem. 2004, 91:501-512.
131. Shano S., Moriyama R., Chun J., Fukushima N. Lysophosphatidic acid stimulates astrocyte proliferation through LPA1. Neurochem. Int. 2008, 52:216-220.
132. Shi J., Dong Y., Cui M.Z., Xu X. Lysophosphatidic acid induces increased BACE1 expression and Aβ formation. Biochim. Biophys. Acta 2013, 1832:29-38.
133. Sigal Y.J., McDermott M.I., Morris A.J. Integral membrane lipid phosphatases/phosphotransferases: common structure and diverse functions. Biochem. J. 2005, 387:281-293.
134. Sisignano M., Angioni C., Ferreiros N., Schuh C.D., Suo J., Schreiber Y., Dawes J.M., Antunes-Martins A., Bennett D.L., McMahon S.B., et al. Synthesis of lipid mediators during UVB-induced inflammatory hyperalgesia in rats and mice. PLoS ONE 2013, 8:e81228.
135. Smesny S., Milleit B., Nenadic I., Preul C., Kinder D., Lasch J., Willhardt I., Sauer H., Gaser C. Phospholipase A2 activity is associated with structural brain changes in schizophrenia. Neuroimage 2010, 52:1314-1327.
136. Sorensen S.D., Nicole O., Peavy R.D., Montoya L.M., Lee C.J., Murphy T.J., Traynelis S.F., Hepler J.R. Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes. Mol. Pharmacol. 2003, 64:1199-1209.
137. Spohr T.C., Choi J.W., Gardell S.E., Herr D.R., Rehen S.K., Gomes F.C., Chun J. Lysophosphatidic acid receptor-dependent secondary effects via astrocytes promote neuronal differentiation. J.Biol. Chem. 2008, 283:7470-7479.
138. Spohr T.C., Dezonne R.S., Rehen S.K., Gomes F.C. Astrocytes treated by lysophosphatidic acid induce axonal outgrowth of cortical progenitors through extracellular matrix protein and epidermal growth factor signaling pathway. J.Neurochem. 2011, 119:113-123.
139. Stankoff B., Barron S., Allard J., Barbin G., Noël F., Aigrot M.S., Premont J., Sokoloff P., Zalc B., Lubetzki C. Oligodendroglial expression of Edg-2 receptor: developmental analysis and pharmacological responses to lysophosphatidic acid. Mol. Cell. Neurosci. 2002, 20:415-428.
140. Strauss U., Bräuer A.U. Current views on regulation and function of plasticity-related genes (PRGs/LPPRs) in the brain. Biochim. Biophys. Acta 2013, 1831:133-138.
141. Sumida H., Noguchi K., Kihara Y., Abe M., Yanagida K., Hamano F., Sato S., Tamaki K., Morishita Y., Kano M.R., et al. LPA4 regulates blood and lymphatic vessel formation during mouse embryogenesis. Blood 2010, 116:5060-5070.
142. Sun Y., Kim N.H., Ji L., Kim S.H., Lee J., Rhee H.J. Lysophosphatidic acid activates betacatenin/T cell factor signaling, which contributes to the suppression of apoptosis in H197 cells. Mol. Med. Rep 2013, 8:1729-1733.
143. Svennerholm L., Boström K., Jungbjer B., Olsson L. Membrane lipids of adult human brain: lipid composition of frontal and temporal lobe in subjects of age 20 to 100 years. J.Neurochem. 1994, 63:1802-1811.
144. Svetlov S.I., Ignatova T.N., Wang K.K., Hayes R.L., English D., Kukekov V.G. Lysophosphatidic acid induces clonal generation of mouse neurospheres via proliferation of Sca-1- and AC133-positive neural progenitors. Stem Cells Dev. 2004, 13:685-693.
145. Tabuchi S., Kume K., Aihara M., Shimizu T. Expression of lysophosphatidic acid receptor in rat astrocytes: mitogenic effect and expression of neurotrophic genes. Neurochem. Res. 2000, 25:573-582.
146. Tanaka M., Okudaira S., Kishi Y., Ohkawa R., Iseki S., Ota M., Noji S., Yatomi Y., Aoki J., Arai H. Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid. J.Biol. Chem. 2006, 281:25822-25830.
147. Taverna E., Götz M., Huttner W.B. The cell biology of neurogenesis: toward an understanding of the development and evolution of the neocortex. Annu. Rev. Cell Dev. Biol. 2014, 30:465-502.
148. Teo S.T., Yung Y.C., Herr D.R., Chun J. Lysophosphatidic acid in vascular development and disease. IUBMB Life 2009, 61:791-799.
149. Tham C.S., Lin F.F., Rao T.S., Yu N., Webb M. Microglial activation state and lysophospholipid acid receptor expression. Int. J. Dev. Neurosci. 2003, 21:431-443.
150. Tigyi G., Hong L., Yakubu M., Parfenova H., Shibata M., Leffler C.W. Lysophosphatidic acid alters cerebrovascular reactivity in piglets. Am. J. Physiol. 1995, 268:H2048-H2055.
151. Tigyi G., Fischer D.J., Sebök A., Yang C., Dyer D.L., Miledi R. Lysophosphatidic acid-induced neurite retraction in PC12 cells: control by phosphoinositide-Ca2+ signaling and Rho. J.Neurochem. 1996, 66:537-548.
152. Triebl A., Trötzmüller M., Eberl A., Hanel P., Hartler J., Köfeler H.C. Quantitation of phosphatidic acid and lysophosphatidic acid molecular species using hydrophilic interaction liquid chromatography coupled to electrospray ionization high resolution mass spectrometry. J.Chromatogr. A 2014, 1347:104-110.
153. Trimbuch T., Beed P., Vogt J., Schuchmann S., Maier N., Kintscher M., Breustedt J., Schuelke M., Streu N., Kieselmann O., et al. Synaptic PRG-1 modulates excitatory transmission via lipid phosphate-mediated signaling. Cell 2009, 138:1222-1235.
154. Tsujiuchi T., Araki M., Hirane M., Dong Y., Fukushima N. Lysophosphatidic acid receptors in cancer pathobiology. Histol. Histopathol. 2014, 29:313-321.
155. Turner C.A., Thompson R.C., Bunney W.E., Schatzberg A.F., Barchas J.D., Myers R.M., Akil H., Watson S.J. Altered choroid plexusgene expression in major depressive disorder. Front. Hum. Neurosci. 2014, 8:238.
156. Ueda H., Matsunaga H., Olaposi O.I., Nagai J. Lysophosphatidic acid: chemical signature of neuropathic pain. Biochim. Biophys. Acta 2013, 1831:61-73.
157. Umemura K., Yamashita N., Yu X., Arima K., Asada T., Makifuchi T., Murayama S., Saito Y., Kanamaru K., Goto Y., et al. Autotaxin expression is enhanced in frontal cortex of Alzheimer-type dementia patients. Neurosci. Lett. 2006, 400:97-100.
158. van Echten-Deckert G., Hagen-Euteneuer N., Karaca I., Walter J. Sphingosine-1-phosphate: boon and bane for the brain. Cell. Physiol. Biochem. 2014, 34:148-157.
159. Van Leeuwen F.N., Olivo C., Grivell S., Giepmans B.N., Collard J.G., Moolenaar W.H. Rac activation by lysophosphatidic acid LPA1 receptors through the guanine nucleotide exchange factor Tiam1. J.Biol. Chem. 2003, 278:400-406.
160. van Meeteren L.A., Ruurs P., Christodoulou E., Goding J.W., Takakusa H., Kikuchi K., Perrakis A., Nagano T., Moolenaar W.H. Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate. J.Biol. Chem. 2005, 280:21155-21161.
161. van Meeteren L.A., Ruurs P., Stortelers C., Bouwman P., van Rooijen M.A., Pradère J.P., Pettit T.R., Wakelam M.J., Saulnier-Blache J.S., Mummery C.L., et al. Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. Mol. Cell. Biol. 2006, 26:5015-5022.
162. Weiner J.A., Chun J. Schwann cell survival mediated by the signaling phospholipid lysophosphatidic acid. Proc. Natl. Acad. Sci. USA 1999, 96:5233-5238.
163. Weiner J.A., Hecht J.H., Chun J. Lysophosphatidic acid receptor gene vzg-1/lpA1/edg-2 is expressed by mature oligodendrocytes during myelination in the postnatal murine brain. J.Comp. Neurol. 1998, 398:587-598.
164. Weiner J.A., Fukushima N., Contos J.J., Scherer S.S., Chun J. Regulation of Schwann cell morphology and adhesion by receptor-mediated lysophosphatidic acid signaling. J.Neurosci. 2001, 21:7069-7078.
165. Willier S., Butt E., Grunewald T.G. Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: a focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays. Biol. Cell 2013, 105:317-333.
166. Wu W.T., Chen C.N., Lin C.I., Chen J.H., Lee H. Lysophospholipids enhance matrix metalloproteinase-2 expression in human endothelial cells. Endocrinology 2005, 146:3387-3400.
167. Yamane M., Furuta D., Fukushima N. Lysophosphatidic acid influences initial neuronal polarity establishment. Neurosci. Lett. 2010, 480:154-157.
168. Yanagida K., Masago K., Nakanishi H., Kihara Y., Hamano F., Tajima Y., Taguchi R., Shimizu T., Ishii S. Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6. J.Biol. Chem. 2009, 284:17731-17741.
169. Yang C., Lafleur J., Mwaikambo B.R., Zhu T., Gagnon C., Chemtob S., Di Polo A., Hardy P. The role of lysophosphatidic acid receptor (LPA1) in the oxygen-induced retinal ganglion cell degeneration. Invest. Ophthalmol. Vis. Sci. 2009, 50:1290-1298.
170. Yu Y., Qin J., Liu M., Ruan Q., Li Y., Zhang Z. Role of Rho kinase in lysophosphatidic acid-induced altering of blood-brain barrier permeability. Int. J. Mol. Med. 2014, 33:661-669.
171. Yukiura H., Hama K., Nakanaga K., Tanaka M., Asaoka Y., Okudaira S., Arima N., Inoue A., Hashimoto T., Arai H., et al. Autotaxin regulates vascular development via multiple lysophosphatidic acid (LPA) receptors in zebrafish. J.Biol. Chem. 2011, 286:43972-43983.
172. Yung Y.C., Kennedy G., Chun J. Identification of neural programmed cell death through the detection of DNA fragmentation insitu and by PCR. Curr. Protoc. Neurosci. 2009, Chapter 3:8.
173. Yung Y.C., Mutoh T., Lin M.E., Noguchi K., Rivera R.R., Choi J.W., Kingsbury M.A., Chun J. Lysophosphatidic acid signaling may initiate fetal hydrocephalus. Sci. Transl. Med. 2011, 3:99ra87.
174. Yung Y.C., Stoddard N.C., Chun J. LPA receptor signaling: pharmacology, physiology, and pathophysiology. J.Lipid Res. 2014, 55:1192-1214.